<code id='5AF0DF3AB1'></code><style id='5AF0DF3AB1'></style>
      • <acronym id='5AF0DF3AB1'></acronym>
      <center id='5AF0DF3AB1'><center id='5AF0DF3AB1'><tfoot id='5AF0DF3AB1'></tfoot></center><abbr id='5AF0DF3AB1'><dir id='5AF0DF3AB1'><tfoot id='5AF0DF3AB1'></tfoot><noframes id='5AF0DF3AB1'>
      • <optgroup id='5AF0DF3AB1'><strike id='5AF0DF3AB1'><sup id='5AF0DF3AB1'></sup></strike><code id='5AF0DF3AB1'></code></optgroup>
        5. <b id='5AF0DF3AB1'><label id='5AF0DF3AB1'><select id='5AF0DF3AB1'><dt id='5AF0DF3AB1'><span id='5AF0DF3AB1'></span></dt></select></label></b><u id='5AF0DF3AB1'></u>
          <i id='5AF0DF3AB1'><strike id='5AF0DF3AB1'><tt id='5AF0DF3AB1'><pre id='5AF0DF3AB1'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / explore / explore      
           
     
           
      
          explore 
           
      
           
      
           
       2025-10-02 02:42:44 
   
      
           
      
           
                        
          explore  
          
                                   
                 
                                      author：knowledge   
                                        
                                      
                                      Page View：156
                                  
                                    
          
                                   
          Adam's take main illustration
          Molly Ferguson/STAT
          Biotech is awash in PIPEs.
          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.
          advertisement
          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          7 more heat
                                
                            
          Next article：  
                                      
                                          What does generative AI mean for health care? We asked experts
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles